INT264242

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.43
First Reported 2007
Last Reported 2010
Negated 0
Speculated 1
Reported most in Body
Documents 2
Total Number 4
Disease Relevance 0.68
Pain Relevance 0.26

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

proteinaceous extracellular matrix (Cpz)
Anatomy Link Frequency
white matter 2
Cpz (Mus musculus)
Pain Link Frequency Relevance Heat
Demyelination 3 90.44 High High
Locus ceruleus 3 79.72 Quite High
Antihistamine 1 78.96 Quite High
cerebral cortex 6 76.84 Quite High
Hippocampus 24 74.76 Quite High
Neurotransmitter 19 61.68 Quite High
withdrawal 6 5.00 Very Low Very Low Very Low
Central nervous system 4 5.00 Very Low Very Low Very Low
anesthesia 4 5.00 Very Low Very Low Very Low
Dopamine 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Psychosis 10 97.00 Very High Very High Very High
Stress 12 93.12 High High
Demyelinating Disease 3 90.44 High High
Death 7 89.72 High High
Vomiting 1 36.56 Quite Low
Targeted Disruption 3 33.76 Quite Low
Schizophrenia 71 5.00 Very Low Very Low Very Low
Cognitive Disorder 15 5.00 Very Low Very Low Very Low
Congenital Anomalies 9 5.00 Very Low Very Low Very Low
Hallucination 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Two years later, in 1957, the importance of CPZ was recognized by the scientific community with the presentation of the American public health association’s prestigious Albert Lasker Award to the three key players in the clinical development of the drug: Henri Laborit, for using CPZ as a therapeutic agent first and recognizing its potential for psychiatry; Pierre Deniker, for his leading role in introducing CPZ into psychiatry and demonstrating its influence on the clinical course of psychosis; and Heinz Lehmann, for bringing the full practical significance of CPZ to the attention of the medical community (Ban 1994).
Positive_regulation (role) of Gene_expression (introducing) of CPZ associated with psychosis
1) Confidence 0.43 Published 2007 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2655089 Disease Relevance 0.10 Pain Relevance 0.04
In summary, CPZ acts on cupric enzymes, including SOD1, cytochrome oxidase, and D?
Positive_regulation (summary) of Gene_expression (acts) of CPZ
2) Confidence 0.41 Published 2010 Journal Frontiers in Behavioral Neuroscience Section Body Doc Link PMC2842101 Disease Relevance 0.51 Pain Relevance 0.11
When CPZ-exposure was extended for 42?
Positive_regulation (When) of Gene_expression (extended) of CPZ-exposure
3) Confidence 0.41 Published 2010 Journal Frontiers in Behavioral Neuroscience Section Body Doc Link PMC2842101 Disease Relevance 0 Pain Relevance 0
This association between normalized DA levels and ameliorated MBP changes in PFC implies that high levels of DA may contribute to the CPZ-induced white matter damage in PFC.
Spec (may) Positive_regulation (contribute) of Gene_expression (damage) of CPZ-induced in white matter
4) Confidence 0.41 Published 2010 Journal Frontiers in Behavioral Neuroscience Section Body Doc Link PMC2842101 Disease Relevance 0.08 Pain Relevance 0.11

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox